Zobrazeno 1 - 10
of 19
pro vyhledávání: '"M S, Barnette"'
Publikováno v:
Neurogastroenterology & Motility. 3:46-52
Changes in cyclic nucleotide content arc associated with relaxation of lower esophageal sphincter (LES) smooth muscle. Although agents that increase cyclic AMP (cAMP) or cyclic CMP (cGMP) can relax the LES, relaxation produced by activation of enteri
Autor:
M Grous, M S Barnette, W. J. Price, W. E. Thompson, M. Fudge, F. C. Barone, A. F. Joslyn, H. S. Ormsbee, C. D. Manning
Publikováno v:
Neurogastroenterology & Motility. 2:65-72
Neuronal stimulation of most isolated precontracted gastrointestinal smooth muscle results in relaxation. This study examined the changes in cyclic nucleotide content associated with neuronally induced relaxation in sphincteric and nonsphincteric smo
Autor:
Rush Ja, Esser Km, L. B. Cieslinski, M S Barnette, T J Torphy, Burman M, Siegfried B. Christensen, Prabhakar Us, Bartus Jo
Publikováno v:
Biochemical Pharmacology. 51:949-956
Phosphodiesterase 4 (PDE4) inhibitors are novel anti-inflammatory compounds. Unfortunately, the archetypal PDE4 inhibitor rolipram produces central nervous system and gastrointestinal side-effects. To exploit these agents, we need to identify PDE4 in
Autor:
M. Grous, M. S. Barnette
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 262:G144-G149
To study the potential of inflammatory mediators to alter colonic motility, we characterized the response of distal colonic smooth muscle to antigen challenge. Addition of ovalbumin to isolated segments of circular smooth muscle obtained from sensiti
Publikováno v:
Gut. 32:4-9
Increases in cyclic adenosine monophosphate and cyclic guanosine monophosphate content accompany relaxation of isolated strips of opossum and canine lower oesophageal sphincter muscle. The aim of this investigation was to characterise these responses
Publikováno v:
Biochemical Pharmacology. 40:1757-1762
Cyclic GMP has been proposed as an intracellular mediator of neuronally-induced relaxation in lower esophageal sphincter (LES) smooth muscle. If cyclic GMP is indeed an intracellular messenger, then agents that activate enteric neurons of the sphinct
Autor:
C D, Manning, M, Burman, S B, Christensen, L B, Cieslinski, D M, Essayan, M, Grous, T J, Torphy, M S, Barnette
Publikováno v:
British journal of pharmacology. 128(7)
1. Of the four major phosphodiesterase 4 (PDE4) subtypes, PDE4A, PDE4B and PDE4D are widely expressed in human inflammatory cells, including monocytes and T lymphocytes. We explored the functional role of these subtypes using ten subtype-selective PD
Autor:
M S, Barnette, S B, Christensen, D M, Essayan, M, Grous, U, Prabhakar, J A, Rush, A, Kagey-Sobotka, T J, Torphy
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 284(1)
First-generation phosphodiesterase 4 (PDE4) inhibitors, such as rolipram, inhibit the activation of immune and inflammatory cells. The clinical use of these compounds is limited by gastrointestinal side effects, such as increased acid secretion and n
Autor:
M. S. Barnette, R. Schleimer
Publikováno v:
Therapeutic Strategies for Modulating the Inflammatory Diseases ISBN: 9783034898041
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::119ec1b01e68dc2d39276dd28c96cbd4
https://doi.org/10.1007/978-3-0348-8857-8_17
https://doi.org/10.1007/978-3-0348-8857-8_17
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 276(2)
Human peripheral blood monocytes were treated for 4 h with a combination of the beta-agonist salbutamol (3 microM) and the low-Km cAMP-specific phosphodiesterase (PDE4) inhibitor rolipram (30 microM) to produce a prolonged elevation of cAMP and conse